НовостиBenzingaPiper Sandler Reiterates Overweight on Pelthos Therapeutics, Lowers Price Target to $21 Piper Sandler Reiterates Overweight on Pelthos Therapeutics, Lowers Price Target to $21 Benzinga 2026.11.13 16:00 (GMT+0) Открыть на Benzinga Другие новости